mTOR信号传导通路相关蛋白与肿瘤治疗

被引：4

作者：

曾波航

刘贵红

江素华

机构：

[1] 广州医学院第二附属医院肿瘤科

来源：

临床药物治疗杂志 | 2010年 / 8卷 / 06期

关键词：

mTOR信号相关蛋白; mTOR信号传导通路; mTOR抑制药; 肿瘤治疗;

D O I：

暂无

中图分类号：

R730.5 [肿瘤治疗学];

学科分类号：

100214 [肿瘤学];

摘要：

哺乳动物雷帕霉素靶蛋白基因位于1p36.2上,其mRNA翻译后的蛋白质有2549个氨基酸残基,其分子结构复杂,分子质量为289kDa。mTOR是一种丝/苏氨酸蛋白激酶,通过调节细胞周期、蛋白质合成、细胞能量代谢等多种通路发挥重要的生理功能,在细胞增殖、生长、分化过程中起着中心调控点的作用。此外,mT0R在肿瘤的形成、发展、转移过程中也起着重要作用。在一些肿瘤中可见mTOR通路的持续活动的现象。到目前为止,mTOR抑制药作为靶向性抗肿瘤药物被有效地应用于肾癌及肝癌等治疗。因此,mTOR信号通路的深入研究对肿瘤的靶向治疗具有重要意义。

引用

页码：13 / 17

页数：5

共 14 条

[1]

Molecularly targeted therapy in hepatocellular carcinoma [J].

Huynh, Hung .

BIOCHEMICAL PHARMACOLOGY, 2010, 80 (05) :550-560

[2]

Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer [J].

Ekstrand, Anna Isinger ;

Jonsson, Mats ;

Lindblom, Annika ;

Borg, Ake ;

Nilbert, Mef .

FAMILIAL CANCER, 2010, 9 (02) :125-129

[3]

Participation of mTOR in the regulation of multidrug resistance of tumor cells.[J].E. A. Scherbakova;E. Yu. Rybalkina;T. P. Stromskaya;A. A. Stavrovskaya.Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology.2009, 2

[4]

The serine 2481-autophosphorylated form of mammalian Target Of Rapamycin (mTOR) is localized to midzone and midbody in dividing cancer cells [J].

Vazquez-Martin, Alejandro ;

Oliveras-Ferraros, Cristina ;

Bernado, Luis ;

Lopez-Bonet, Eugeni ;

Menendez, Javier A. .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 380 (03) :638-643

[5]

Chapter 2 PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis.[J].Bing‐Hua Jiang;Ling‐Zhi Liu.Advances in Cancer Research.2009,

[6]

Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment [J].

Jiang, Bing-Hua ;

Liu, Ling-Zhi .

DRUG RESISTANCE UPDATES, 2008, 11 (03) :63-76

[7]

An Attractive Therapeutic Target; mTOR Pathway; in ALK+ Anaplastic Large Cell Lymphoma.[J].Jeong Hee Cho-Vega;Francisco Vega;L. Jeffrey Medeiros.Advances in Anatomic Pathology.2008, 2

[8]

Rapamycin and mTOR kinase inhibitors.[J].Lisa M. Ballou;Richard Z. Lin.Journal of Chemical Biology.2008, 1

[9]

Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables [J].